AstraZeneca PLC (AZN)
FDA Applications
Note: This list only includes applications that have been responded to by the FDA.
Application | Product Name | Active Ingredient | Form | Strength | Status | ||
---|---|---|---|---|---|---|---|
BLA761328 - ASTRAZENECA AB | |||||||
BEYFORTUS | NIRSEVIMAB-ALIP | INJECTABLE;INJECTION | 50MG | Prescription | |||
BEYFORTUS | NIRSEVIMAB-ALIP | INJECTABLE;INJECTION | 100MG | Prescription | |||
BLA761289 - ASTRAZENECA AB | |||||||
IMJUDO | TREMELIMUMAB-ACTL | INJECTABLE;INTRAVENOUS | 25MG/1.25ML(20MG/ML) | Prescription | |||
IMJUDO | TREMELIMUMAB-ACTL | INJECTABLE;INTRAVENOUS | 300MG/15ML(20MG/ML) | Prescription | |||
BLA761270 - ASTRAZENECA AB | |||||||
IMJUDO | TREMELIMUMAB-ACTL | INJECTABLE;INTRAVENOUS | 25MG/1.25ML(20MG/ML) | Prescription | |||
IMJUDO | TREMELIMUMAB-ACTL | INJECTABLE;INTRAVENOUS | 300MG/15ML(20MG/ML) | Prescription | |||
BLA761224 - ASTRAZENECA AB | |||||||
TEZSPIRE | TEZEPELUMAB-EKKO | SOLUTION;SUBCUTANEOUS | 210MG/1.91ML(110MG/ML) | Prescription | |||
BLA761123 - ASTRAZENECA AB | |||||||
SAPHNELO | ANIFROLUMAB-FNIA | INJECTABLE;INJECTION | 300MG/2ML(150MG/ML) | Prescription | |||
BLA761070 - ASTRAZENECA AB | |||||||
FASENRA | BENRALIZUMAB | INJECTABLE;INJECTION | 30MG/ML | Prescription | |||
BLA761069 - ASTRAZENECA UK LTD | |||||||
IMFINZI | DURVALUMAB | INJECTABLE;INJECTION | 50MG/ML | Prescription | |||
NDA218197 - ASTRAZENECA | |||||||
TRUQAP | CAPIVASERTIB | TABLET;ORAL | 160MG | Prescription | |||
TRUQAP | CAPIVASERTIB | TABLET;ORAL | 200MG | Prescription | |||
NDA217388 - ASTRAZENECA AB | |||||||
WAINUA (AUTOINJECTOR) | EPLONTERSEN SODIUM | SOLUTION;SUBCUTANEOUS | EQ 45MG BASE/0.8ML (EQ 45MG BASE/0.8ML) | Prescription | |||
NDA216579 - ASTRAZENECA | |||||||
SYMBICORT AEROSPHERE | BUDESONIDE; FORMOTEROL FUMARATE | AEROSOL, METERED;INHALATION | 0.16MG/INH;0.0048MG/INH | Prescription | |||
NDA216387 - ASTRAZENECA | |||||||
CALQUENCE | ACALABRUTINIB MALEATE | TABLET;ORAL | EQ 100MG BASE | Prescription | |||
NDA214070 - ASTRAZENECA | |||||||
AIRSUPRA | ALBUTEROL SULFATE; BUDESONIDE | AEROSOL, METERED;INHALATION | EQ 0.09MG BASE/INH;0.08MG/INH | Prescription | |||
NDA213756 - ASTRAZENECA | |||||||
KOSELUGO | SELUMETINIB SULFATE | CAPSULE;ORAL | EQ 25MG BASE | Prescription | |||
KOSELUGO | SELUMETINIB SULFATE | CAPSULE;ORAL | EQ 10MG BASE | Prescription | |||
NDA212122 - ASTRAZENECA AB | |||||||
BREZTRI AEROSPHERE | BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | AEROSOL, METERED;INHALATION | 0.16MG/INH;0.0048MG/INH;0.009MG/INH | Prescription | |||
NDA210874 - ASTRAZENECA AB | |||||||
QTERNMET XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 2.5MG;1GM;EQ 2.5MG BASE | Discontinued | |||
QTERNMET XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 5MG;1GM;EQ 2.5MG BASE | Discontinued | |||
QTERNMET XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 5MG;1GM;EQ 5MG BASE | Discontinued | |||
QTERNMET XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MG;1GM;EQ 5MG BASE | Discontinued | |||
NDA210259 - ASTRAZENECA | |||||||
CALQUENCE | ACALABRUTINIB | CAPSULE;ORAL | 100MG | Prescription | |||
NDA209210 - ASTRAZENECA AB | |||||||
BYDUREON BCISE | EXENATIDE SYNTHETIC | SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 2MG/0.85ML (2MG/0.85ML) | Prescription | |||
NDA209091 - ASTRAZENECA AB | |||||||
QTERN | DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE | TABLET;ORAL | 5MG;EQ 5MG BASE | Prescription | |||
QTERN | DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE | TABLET;ORAL | 10MG;EQ 5MG BASE | Prescription | |||
NDA208558 - ASTRAZENECA | |||||||
LYNPARZA | OLAPARIB | TABLET;ORAL | 150MG | Prescription | |||
LYNPARZA | OLAPARIB | TABLET;ORAL | 100MG | Prescription | |||
NDA208294 - ASTRAZENECA | |||||||
BEVESPI AEROSPHERE | FORMOTEROL FUMARATE; GLYCOPYRROLATE | AEROSOL, METERED;INHALATION | 0.0048MG/INH;0.0090MG/INH | Prescription | |||
NDA208065 - ASTRAZENECA | |||||||
TAGRISSO | OSIMERTINIB MESYLATE | TABLET;ORAL | EQ 80MG BASE | Prescription | |||
TAGRISSO | OSIMERTINIB MESYLATE | TABLET;ORAL | EQ 40MG BASE | Prescription | |||
NDA207920 - ASTRAZENECA LP | |||||||
NEXIUM 24HR | ESOMEPRAZOLE MAGNESIUM | TABLET, DELAYED RELEASE;ORAL | EQ 20MG BASE | Over-the-counter | |||
NDA207078 - ASTRAZENECA | |||||||
LOKELMA | SODIUM ZIRCONIUM CYCLOSILICATE | FOR SUSPENSION;ORAL | 5GM/PACKET | Prescription | |||
LOKELMA | SODIUM ZIRCONIUM CYCLOSILICATE | FOR SUSPENSION;ORAL | 10GM/PACKET | Prescription | |||
NDA206995 - ASTRAZENECA | |||||||
IRESSA | GEFITINIB | TABLET;ORAL | 250MG | Prescription | |||
NDA206162 - ASTRAZENECA | |||||||
LYNPARZA | OLAPARIB | CAPSULE;ORAL | 50MG | Discontinued | |||
NDA205649 - ASTRAZENECA AB | |||||||
XIGDUO XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 5MG;500MG | Prescription | |||
XIGDUO XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 5MG;1GM | Prescription | |||
XIGDUO XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MG;500MG | Prescription | |||
XIGDUO XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MG;1GM | Prescription | |||
XIGDUO XR | DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 2.5MG;1GM | Prescription | |||
NDA205060 - ASTRAZENECA | |||||||
EPANOVA | OMEGA-3-CARBOXYLIC ACIDS | CAPSULE;ORAL | 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS | Discontinued | |||
NDA204655 - ASTRAZENECA LP | |||||||
NEXIUM 24HR | ESOMEPRAZOLE MAGNESIUM | CAPSULE, DELAYED RELEASE;ORAL | EQ 20MG BASE | Over-the-counter | |||
NDA202293 - ASTRAZENECA AB | |||||||
FARXIGA | DAPAGLIFLOZIN | TABLET;ORAL | 5MG | Prescription | |||
FARXIGA | DAPAGLIFLOZIN | TABLET;ORAL | 10MG | Prescription | |||
NDA200678 - ASTRAZENECA AB | |||||||
KOMBIGLYZE XR | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 500MG;EQ 5MG BASE | Discontinued | |||
KOMBIGLYZE XR | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 1GM;EQ 5MG BASE | Discontinued | |||
KOMBIGLYZE XR | METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 1GM;EQ 2.5MG BASE | Discontinued | |||
ANDA089618 - ASTRAZENECA | |||||||
ISOETHARINE HYDROCHLORIDE | ISOETHARINE HYDROCHLORIDE | SOLUTION;INHALATION | 0.25% | Discontinued | |||
ANDA089617 - ASTRAZENECA | |||||||
ISOETHARINE HYDROCHLORIDE | ISOETHARINE HYDROCHLORIDE | SOLUTION;INHALATION | 0.2% | Discontinued | |||
ANDA089616 - ASTRAZENECA | |||||||
ISOETHARINE HYDROCHLORIDE | ISOETHARINE HYDROCHLORIDE | SOLUTION;INHALATION | 0.167% | Discontinued | |||
ANDA089615 - ASTRAZENECA | |||||||
ISOETHARINE HYDROCHLORIDE | ISOETHARINE HYDROCHLORIDE | SOLUTION;INHALATION | 0.125% | Discontinued | |||
ANDA089614 - ASTRAZENECA | |||||||
ISOETHARINE HYDROCHLORIDE | ISOETHARINE HYDROCHLORIDE | SOLUTION;INHALATION | 0.062% | Discontinued | |||
ANDA088472 - ASTRAZENECA | |||||||
ISOETHARINE HYDROCHLORIDE | ISOETHARINE HYDROCHLORIDE | SOLUTION;INHALATION | 0.25% | Discontinued | |||
ANDA088471 - ASTRAZENECA | |||||||
ISOETHARINE HYDROCHLORIDE | ISOETHARINE HYDROCHLORIDE | SOLUTION;INHALATION | 0.2% | Discontinued | |||
ANDA088470 - ASTRAZENECA | |||||||
ISOETHARINE HYDROCHLORIDE | ISOETHARINE HYDROCHLORIDE | SOLUTION;INHALATION | 0.167% | Discontinued | |||
ANDA088125 - ASTRAZENECA | |||||||
SORBITRATE | ISOSORBIDE DINITRATE | TABLET;ORAL | 40MG | Discontinued | |||
ANDA088124 - ASTRAZENECA | |||||||
SORBITRATE | ISOSORBIDE DINITRATE | TABLET;ORAL | 30MG | Discontinued | |||
ANDA087938 - ASTRAZENECA | |||||||
ISOETHARINE HYDROCHLORIDE | ISOETHARINE HYDROCHLORIDE | SOLUTION;INHALATION | 0.125% | Discontinued | |||
ANDA087937 - ASTRAZENECA | |||||||
ISOETHARINE HYDROCHLORIDE | ISOETHARINE HYDROCHLORIDE | SOLUTION;INHALATION | 0.062% | Discontinued | |||
ANDA086405 - ASTRAZENECA | |||||||
SORBITRATE | ISOSORBIDE DINITRATE | TABLET;ORAL | 20MG | Discontinued | |||
ANDA083080 - ASTRAZENECA | |||||||
AQUASOL A | VITAMIN A | CAPSULE;ORAL | 25,000USP UNITS | Discontinued | |||
AQUASOL A | VITAMIN A | CAPSULE;ORAL | 50,000USP UNITS | Discontinued | |||
ANDA072081 - ASTRAZENECA | |||||||
NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.02MG/ML | Discontinued | |||
ANDA072028 - ASTRAZENECA | |||||||
FENTANYL CITRATE AND DROPERIDOL | DROPERIDOL; FENTANYL CITRATE | INJECTABLE;INJECTION | 2.5MG/ML;EQ 0.05MG BASE/ML | Discontinued | |||
ANDA072027 - ASTRAZENECA | |||||||
FENTANYL CITRATE AND DROPERIDOL | DROPERIDOL; FENTANYL CITRATE | INJECTABLE;INJECTION | 2.5MG/ML;EQ 0.05MG BASE/ML | Discontinued | |||
ANDA072026 - ASTRAZENECA | |||||||
FENTANYL CITRATE AND DROPERIDOL | DROPERIDOL; FENTANYL CITRATE | INJECTABLE;INJECTION | 2.5MG/ML;EQ 0.05MG BASE/ML | Discontinued | |||
ANDA072018 - ASTRAZENECA | |||||||
DROPERIDOL | DROPERIDOL | INJECTABLE;INJECTION | 2.5MG/ML | Discontinued | |||
ANDA071275 - ASTRAZENECA | |||||||
METAPROTERENOL SULFATE | METAPROTERENOL SULFATE | SOLUTION;INHALATION | 0.4% | Discontinued | |||
ANDA071153 - ASTRAZENECA | |||||||
BRETYLIUM TOSYLATE | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | 50MG/ML | Discontinued | |||
ANDA071152 - ASTRAZENECA | |||||||
BRETYLIUM TOSYLATE | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | 50MG/ML | Discontinued | |||
ANDA071151 - ASTRAZENECA | |||||||
BRETYLIUM TOSYLATE | BRETYLIUM TOSYLATE | INJECTABLE;INJECTION | 50MG/ML | Discontinued | |||
ANDA071018 - ASTRAZENECA | |||||||
METAPROTERENOL SULFATE | METAPROTERENOL SULFATE | SOLUTION;INHALATION | 0.6% | Discontinued | |||
ANDA070014 - ASTRAZENECA | |||||||
FUROSEMIDE | FUROSEMIDE | INJECTABLE;INJECTION | 10MG/ML | Discontinued | |||
NDA022522 - ASTRAZENECA | |||||||
DALIRESP | ROFLUMILAST | TABLET;ORAL | 250MCG | Prescription | |||
DALIRESP | ROFLUMILAST | TABLET;ORAL | 500MCG | Prescription | |||
NDA022433 - ASTRAZENECA | |||||||
BRILINTA | TICAGRELOR | TABLET;ORAL | 60MG | Prescription | |||
BRILINTA | TICAGRELOR | TABLET;ORAL | 90MG | Prescription | |||
NDA022350 - ASTRAZENECA AB | |||||||
ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | TABLET;ORAL | EQ 2.5MG BASE | Discontinued | |||
ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | TABLET;ORAL | EQ 5MG BASE | Discontinued | |||
NDA022310 - ASTRAZENECA | |||||||
CASODEX | BICALUTAMIDE | TABLET; ORAL | 50MG | Prescription | |||
NDA022214 - ASTRAZENECA | |||||||
ARIMIDEX | ANASTROZOLE | TABLET; ORAL | 1MG | Prescription | |||
NDA022200 - ASTRAZENECA AB | |||||||
BYDUREON | EXENATIDE SYNTHETIC | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 2MG/VIAL | Discontinued | |||
BYDUREON PEN | EXENATIDE SYNTHETIC | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 2MG | Discontinued | |||
NDA022172 - ASTRAZENECA | |||||||
SEROQUEL XR | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE; ORAL | 50MG | Prescription | |||
SEROQUEL XR | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE; ORAL | 200MG | Prescription | |||
SEROQUEL XR | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE; ORAL | 300MG | Prescription | |||
SEROQUEL XR | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE; ORAL | 400MG | Prescription | |||
NDA022101 - ASTRAZENECA | |||||||
NEXIUM | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | EQ 10MG BASE/PACKET | Prescription | |||
NDA022047 - ASTRAZENECA | |||||||
SEROQUEL XR | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 50MG BASE | Prescription | |||
SEROQUEL XR | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 200MG BASE | Prescription | |||
SEROQUEL XR | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 300MG BASE | Prescription | |||
SEROQUEL XR | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 400MG BASE | Prescription | |||
SEROQUEL XR | QUETIAPINE FUMARATE | TABLET, EXTENDED RELEASE;ORAL | EQ 150MG BASE | Prescription | |||
NDA021957 - ASTRAZENECA | |||||||
NEXIUM | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | EQ 2.5MG BASE/PACKET | Prescription | |||
NEXIUM | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | EQ 5MG BASE/PACKET | Prescription | |||
NEXIUM | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | EQ 20MG BASE/PACKET | Prescription | |||
NEXIUM | ESOMEPRAZOLE MAGNESIUM | FOR SUSPENSION, DELAYED RELEASE;ORAL | EQ 40MG BASE/PACKET | Prescription | |||
NDA021929 - ASTRAZENECA | |||||||
SYMBICORT | BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE | AEROSOL, METERED;INHALATION | 0.16MG/INH;0.0045MG/INH | Prescription | |||
SYMBICORT | BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE | AEROSOL, METERED;INHALATION | 0.08MG/INH;0.0045MG/INH | Prescription | |||
NDA021773 - ASTRAZENECA AB | |||||||
BYETTA | EXENATIDE SYNTHETIC | INJECTABLE;SUBCUTANEOUS | 300MCG/1.2ML (250MCG/ML) | Prescription | |||
BYETTA | EXENATIDE SYNTHETIC | INJECTABLE;SUBCUTANEOUS | 600MCG/2.4ML (250MCG/ML) | Prescription | |||
NDA021689 - ASTRAZENECA | |||||||
NEXIUM IV | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 40MG BASE/VIAL | Discontinued | |||
NEXIUM IV | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA021399 - ASTRAZENECA | |||||||
IRESSA | GEFITINIB | TABLET;ORAL | 250MG | Discontinued | |||
NDA021344 - ASTRAZENECA | |||||||
FASLODEX | FULVESTRANT | SOLUTION;INTRAMUSCULAR | 125MG/2.5ML (50MG/ML) | Discontinued | |||
FASLODEX | FULVESTRANT | SOLUTION;INTRAMUSCULAR | 250MG/5ML (50MG/ML) | Prescription | |||
NDA021332 - ASTRAZENECA AB | |||||||
SYMLIN | PRAMLINTIDE ACETATE | INJECTABLE;SUBCUTANEOUS | EQ 3MG BASE/5ML (EQ 600MCG BASE/ML) | Discontinued | |||
SYMLIN | PRAMLINTIDE ACETATE | INJECTABLE;SUBCUTANEOUS | EQ 1.5MG BASE/1.5ML (EQ 1MG BASE/ML) | Prescription | |||
SYMLIN | PRAMLINTIDE ACETATE | INJECTABLE;SUBCUTANEOUS | EQ 2.7MG BASE/2.7ML (EQ 1MG BASE/ML) | Prescription | |||
NDA021311 - ASTRAZENECA PHARMS | |||||||
NDA021231 - ASTRAZENECA | |||||||
ZOMIG-ZMT | ZOLMITRIPTAN | TABLET, ORALLY DISINTEGRATING;ORAL | 5MG | Discontinued | |||
ZOMIG-ZMT | ZOLMITRIPTAN | TABLET, ORALLY DISINTEGRATING;ORAL | 2.5MG | Discontinued | |||
NDA021229 - ASTRAZENECA | |||||||
PRILOSEC OTC | OMEPRAZOLE MAGNESIUM | TABLET, DELAYED RELEASE;ORAL | EQ 20MG BASE | Over-the-counter | |||
NDA021153 - ASTRAZENECA | |||||||
NEXIUM | ESOMEPRAZOLE MAGNESIUM | CAPSULE, DELAYED REL PELLETS;ORAL | EQ 40MG BASE | Prescription | |||
NEXIUM | ESOMEPRAZOLE MAGNESIUM | CAPSULE, DELAYED REL PELLETS;ORAL | EQ 20MG BASE | Prescription | |||
NDA020962 - ASTRAZENECA | |||||||
EMLA | LIDOCAINE; PRILOCAINE | DISC;TOPICAL | 2.5%;2.5% | Discontinued | |||
NDA020929 - ASTRAZENECA | |||||||
PULMICORT RESPULES | BUDESONIDE | SUSPENSION;INHALATION | 1MG/2ML | Prescription | |||
PULMICORT RESPULES | BUDESONIDE | SUSPENSION;INHALATION | 0.25MG/2ML | Prescription | |||
PULMICORT RESPULES | BUDESONIDE | SUSPENSION;INHALATION | 0.5MG/2ML | Prescription | |||
NDA020668 - ASTRAZENECA | |||||||
LEXXEL | ENALAPRIL MALEATE; FELODIPINE | TABLET, EXTENDED RELEASE;ORAL | 5MG;2.5MG | Discontinued | |||
LEXXEL | ENALAPRIL MALEATE; FELODIPINE | TABLET, EXTENDED RELEASE;ORAL | 5MG;5MG | Discontinued | |||
NDA020639 - ASTRAZENECA | |||||||
SEROQUEL | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
SEROQUEL | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 300MG BASE | Prescription | |||
SEROQUEL | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 400MG BASE | Prescription | |||
SEROQUEL | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 200MG BASE | Prescription | |||
SEROQUEL | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 25MG BASE | Prescription | |||
SEROQUEL | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 100MG BASE | Prescription | |||
SEROQUEL | QUETIAPINE FUMARATE | TABLET;ORAL | EQ 50MG BASE | Prescription | |||
NDA020441 - ASTRAZENECA | |||||||
PULMICORT | BUDESONIDE | POWDER, METERED;INHALATION | 0.32MG/INH | Discontinued | |||
PULMICORT | BUDESONIDE | POWDER, METERED;INHALATION | 0.16MG/INH | Discontinued | |||
NDA020233 - ASTRAZENECA | |||||||
RHINOCORT | BUDESONIDE | AEROSOL, METERED;NASAL | 0.032MG/INH | Discontinued | |||
NDA019834 - ASTRAZENECA | |||||||
PLENDIL | FELODIPINE | TABLET, EXTENDED RELEASE;ORAL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
PLENDIL | FELODIPINE | TABLET, EXTENDED RELEASE;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
PLENDIL | FELODIPINE | TABLET, EXTENDED RELEASE;ORAL | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA019810 - ASTRAZENECA | |||||||
PRILOSEC | OMEPRAZOLE | CAPSULE, DELAYED REL PELLETS;ORAL | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
PRILOSEC | OMEPRAZOLE | CAPSULE, DELAYED REL PELLETS;ORAL | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
PRILOSEC | OMEPRAZOLE | CAPSULE, DELAYED REL PELLETS;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA019082 - ASTRAZENECA | |||||||
DALGAN | DEZOCINE | INJECTABLE;INJECTION | 10MG/ML | Discontinued | |||
DALGAN | DEZOCINE | INJECTABLE;INJECTION | 15MG/ML | Discontinued | |||
DALGAN | DEZOCINE | INJECTABLE;INJECTION | 5MG/ML | Discontinued | |||
NDA019058 - ASTRAZENECA | |||||||
TENORMIN | ATENOLOL | INJECTABLE;INJECTION | 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA018580 - ASTRAZENECA | |||||||
YUTOPAR | RITODRINE HYDROCHLORIDE | INJECTABLE;INJECTION | 10MG/ML | Discontinued | |||
YUTOPAR | RITODRINE HYDROCHLORIDE | INJECTABLE;INJECTION | 15MG/ML | Discontinued | |||
NDA018555 - ASTRAZENECA | |||||||
YUTOPAR | RITODRINE HYDROCHLORIDE | TABLET;ORAL | 10MG | Discontinued | |||
NDA018257 - ASTRAZENECA | |||||||
TONOCARD | TOCAINIDE HYDROCHLORIDE | TABLET;ORAL | 400MG | Discontinued | |||
TONOCARD | TOCAINIDE HYDROCHLORIDE | TABLET;ORAL | 600MG | Discontinued | |||
NDA017970 - ASTRAZENECA | |||||||
NOLVADEX | TAMOXIFEN CITRATE | TABLET;ORAL | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NOLVADEX | TAMOXIFEN CITRATE | TABLET;ORAL | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA017751 - ASTRAZENECA | |||||||
DURANEST | ETIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
DURANEST | EPINEPHRINE; ETIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
DURANEST | ETIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
DURANEST | EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
DURANEST | EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA016776 - ASTRAZENECA | |||||||
SORBITRATE | ISOSORBIDE DINITRATE | TABLET, CHEWABLE;ORAL | 5MG | Discontinued | |||
SORBITRATE | ISOSORBIDE DINITRATE | TABLET, CHEWABLE;ORAL | 10MG | Discontinued | |||
NDA016192 - ASTRAZENECA | |||||||
SORBITRATE | ISOSORBIDE DINITRATE | TABLET;ORAL | 5MG | Discontinued | |||
SORBITRATE | ISOSORBIDE DINITRATE | TABLET;ORAL | 10MG | Discontinued | |||
NDA016191 - ASTRAZENECA | |||||||
SORBITRATE | ISOSORBIDE DINITRATE | TABLET;SUBLINGUAL | 5MG | Discontinued | |||
SORBITRATE | ISOSORBIDE DINITRATE | TABLET;SUBLINGUAL | 2.5MG | Discontinued | |||
NDA014763 - ASTRAZENECA | |||||||
CITANEST | PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
CITANEST | PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
CITANEST | PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
CITANEST PLAIN | PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
CITANEST FORTE | EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;4% | Discontinued | |||
NDA014394 - ASTRAZENECA | |||||||
XYLOCAINE | LIDOCAINE | AEROSOL;ORAL | 10% | Discontinued | |||
NDA014127 - ASTRAZENECA | |||||||
XYLOCAINE | LIDOCAINE | SOLUTION;TOPICAL | 5% | Discontinued | |||
NDA013077 - ASTRAZENECA | |||||||
XYLOCAINE | LIDOCAINE | SUPPOSITORY;RECTAL | 100MG | Discontinued | |||
NDA012704 - ASTRAZENECA | |||||||
ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | INJECTABLE;INJECTION | 10MG/ML | Discontinued | |||
NDA012703 - ASTRAZENECA | |||||||
ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
ELAVIL | AMITRIPTYLINE HYDROCHLORIDE | TABLET;ORAL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA010496 - ASTRAZENECA | |||||||
XYLOCAINE 5% W/ GLUCOSE 7.5% | LIDOCAINE HYDROCHLORIDE | INJECTABLE;SPINAL | 5% | Discontinued | |||
NDA010418 - ASTRAZENECA | |||||||
XYLOCAINE | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1% | Discontinued | |||
XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;1% | Discontinued | |||
XYLOCAINE | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 2% | Discontinued | |||
XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;2% | Discontinued | |||
XYLOCAINE | LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1.5% | Discontinued | |||
XYLOCAINE W/ EPINEPHRINE | EPINEPHRINE; LIDOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.005MG/ML;1.5% | Discontinued | |||
NDA009925 - ASTRAZENECA | |||||||
DYCLONE | DYCLONINE HYDROCHLORIDE | SOLUTION;TOPICAL | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
DYCLONE | DYCLONINE HYDROCHLORIDE | SOLUTION;TOPICAL | 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued | |||
NDA008048 - ASTRAZENECA | |||||||
XYLOCAINE | LIDOCAINE | OINTMENT;TOPICAL | 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Discontinued |